LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney.

Feingold, Kenneth R; Wang, Yuwei; Moser, Arthur; Shigenaga, Judy K; Grunfeld, Carl

Feingold, Kenneth R; Wang, Yuwei; Moser, Arthur; Shigenaga, Judy K; Grunfeld, Carl.

Affiliation

Feingold KR; Metabolism Section, Department of Veterans Affairs Medical Center, San Francisco, CA, USA. kfngld@itsa.ucsf.edu

J Lipid Res ; 49(10): 2179-87, 2008 Oct.

Article in En | MEDLINE | ID: mdl-18574256

Subject(s)

Fatty Acids/metabolism; Kidney/drug effects; Kidney/metabolism; Lipopolysaccharides/pharmacology; Receptors, Cytoplasmic and Nuclear/metabolism; Animals; Fatty Acids/genetics; Female; Gene Expression Regulation/drug effects; Male; Mice; Oxidation-Reduction/drug effects; Peroxisome Proliferator-Activated Receptors/deficiency; Peroxisome Proliferator-Activated Receptors/genetics; RNA, Messenger/genetics; RNA, Messenger/metabolism; Receptors, Thyroid Hormone/genetics; Triglycerides/blood

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lipopolysaccharides / Receptors, Cytoplasmic and Nuclear / Fatty Acids / Kidney Limits: Animals Language: En Journal: J Lipid Res Year: 2008 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google